| 生物活性 | |||
|---|---|---|---|
| 靶点 |
|
||
| 描述 | Azathioprine is an immunosuppressive drug, inhibiting purine synthesis and GTP-binding protein Rac1 activation, used in the treatment of organ transplantation and autoimmune diseases. | ||
| 临床研究 | |||||
|---|---|---|---|---|---|
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT00745329 | - | Unknown | - | - | |
| NCT01235689 | Crohn's Disease | Phase 3 | Completed | - | - |
| NCT00615173 | Kidney Diseases ... 展开 >> Lupus Nephritis Tacrolimus Induction Phase Maintenance Phase 收起 << | Phase 3 | Completed | - | China, Guangdong ... 展开 >> The 1st Affiliated Hospital, Sun Yet-sen University Guangzhou, Guangdong, China, 510080 收起 << |
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
3.61mL 0.72mL 0.36mL |
18.03mL 3.61mL 1.80mL |
36.07mL 7.21mL 3.61mL |
| 参考文献 |
|---|